SCHEMBL4903708

SCHEMBL4903708

CCc1ccc(S(=O)(=O)N(CC)Sc2ncccc2C(F)(F)F)cc1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
ALDH1A1 P00352 6/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
RAB9A P51151 1/20 0.38
PTGDR2 Q9Y5Y4 3/20 0.37
DHODH Q02127 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HSD11B1 P28845 1/20 0.35
TRPM8 Q7Z2W7 3/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HTT P42858 2/20 0.34
MDM4 O15151 1/20 0.34
MITF O75030 1/20 0.34
MDM2 Q00987 1/20 0.34
ATM Q13315 1/20 0.34
GPR35 Q9HC97 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907293 0.90 LMNA (0.39) LMNAALDH1A1SMN1; SMN2RAB9APTGDR2
SCHEMBL4904091 0.90 ALDH1A1 (0.40) LMNAALDH1A1SMN1; SMN2PTGDR2HSD11B1
SCHEMBL4899957 0.82 ALDH1A1 (0.40) LMNAALDH1A1SMN1; SMN2RAB9APTGDR2
SCHEMBL4905186 0.79 KMT2A (0.47) LMNAALDH1A1SMN1; SMN2TRPM8L3MBTL1
SCHEMBL4895514 0.78 LMNA (0.40) LMNAALDH1A1SMN1; SMN2PTGDR2HDAC6
SCHEMBL4905476 0.78 ALDH1A1 (0.40) LMNAALDH1A1RAB9APTGDR2TRPM8
SCHEMBL4903694 0.77 ALDH1A1 (0.40) LMNAALDH1A1SMN1; SMN2RAB9APTGDR2
SCHEMBL4906037 0.73 ALDH1A1 (0.44) LMNAALDH1A1SMN1; SMN2HDAC6TRPM8
SCHEMBL4898117 0.73 ALDH1A1 (0.40) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4900993 0.70 LMNA (0.38) LMNAALDH1A1HPGDALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885SMN1; SMN2 3404/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885SMN1; SMN2 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.